PT - JOURNAL ARTICLE AU - Darwesh Badawy, Mohammed Abd ElFattah Mohammed AU - Naing, Lin AU - Tuah, Nik Ani Afiqah TI - Comparison of Screening Guidelines for Cardiovascular disease Prevention and Early Detection: <em>a scoping review</em> AID - 10.1101/2023.08.05.23293697 DP - 2023 Jan 01 TA - medRxiv PG - 2023.08.05.23293697 4099 - http://medrxiv.org/content/early/2023/08/07/2023.08.05.23293697.short 4100 - http://medrxiv.org/content/early/2023/08/07/2023.08.05.23293697.full AB - Objective Globally, cardiovascular disease (CVD) has a significant role in morbidity and early death. This review’s objective is to provide a summary of the strengths and weaknesses in the variety of screening guidelines made by several international organizations for the early identification and prevention of CVD.Methods As the reporting guideline for this review, we used Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR). We performed a scoping review using a few guideline-specific databases. We tabulated the main key differences between the included screening guidelines for CVD prevention and early detection from different perspectives.Results We included a total of 20 unique guidelines that were developed by various organizations throughout the world and focused on screening for CVD prevention and early detection out of the 2,466 guidelines discovered by our search based on our eligibility criteria. We concluded that the target populations, CVD risk assessment techniques, outcomes, and categories of the chosen CVD prevention guidelines widely varied. Additionally, some guidelines adopted no grading scheme for their evidence, while others did not advocate the use of any imaging screening tools in their evaluation of the CVD risk.Conclusions This scoping review highlights the areas of each guideline’s strengths and weaknesses and conducts a systematic comparison of a number of worldwide guidelines for CVD prevention and early diagnosis.What is already known in this review?Based on the most recent evidence and consensus among experts, each nation creates its own set of guidelines for the early detection and prevention of CVD.What this review adds This review conducted a systematic comparison and summarized the strengths and weaknesses of the various screening guidelines made by numerous international organizations for the early detection and prevention of CVD.• How this review might affect research, practice or policyThis review provided opportunities to improve the future development of the clinical practice guidelines for CVD prevention and early detection.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Universiti Brunei Darussalam, Brunei Darussalam.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript.ABIAnkle-branchial IndexACCF/AHAThe American College of Cardiology Foundation and the American Heart AssociationADAAmerican Diabetes AssociationAGREE IIAppraisal of Guidelines for Research and Evaluation IIAHA/ACCThe American Heart Association and The American College of CardiologyASSIGNASsessing cardiovascular risk using SIGN guidelines to ASSIGN preventive treatmentCACCoronary Artery CalciumCADcoronary artery diseaseC-CHANGECanadian Cardiovascular Harmonized National Guidelines EndeavourcIMTCarotid Intima-Media ThicknessCPGClinical practice guidelineCTComputed TomographyCVDCardiovascular diseaseCVDRACVD risk assessmentEAPCEuropean Association of Preventive CardiologyECGelectrocardiogramESCEuropean Society of CardiologyGRADEThe Grading of Recommendations Assessment, Development and EvaluationISHInternational Society of HypertensionJBSJoint British Societies’ GuidelinesMOHMinistry of HealthMPImyocardial perfusion imagingNCDsNoncommunicable DiseasesNCEP ATPNational Cholesterol Education Program’s Adult Treatment PanelNHMRCNational Health and Medical Research CouncilNHSNational Health ServicesNICENational Institute for Health and Care ExcellenceNVDPAThe National Vascular Disease Prevention AlliancePRISMA-ScRSystematic reviews and Meta-Analyses extension for Scoping ReviewsPWVaortic pulse wave velocitySCORESystematic Coronary Risk EstimationSCORE2-OPUpdated SCORE for old peopleSHAPEScreening for Heart Attack Prevention and EducationSIGNScottish Intercollegiate Guidelines NetworkUKUnited KingdomWHOWorld Health OrganizationWPR-AWestern Pacific Region A